Polyethylene glycol 400 (PEG 400) is a clinically useful intestinal permeability probe whose rate of intestinal permeation is influenced in part by solvent drag. As mucosal prostanoids are increased in inflammatory bowel disease and affect water transport we examined the possible relationship between prostaglandin E2 (PGE2) and the inhibitors of endogenous prostaglandins -the non-steroidal anti-inflammatory drugs (NSAIDS) -on PEG 400 absorption in vivo using segmental perfusion of rat small intestine. We found that the addition of exogenous PGE2 in concentrations of 0*5, 1.0, and 1*5 pg/ml significantly (p<OOl) decreased PEG 400 and water absorption. Addition of 5 mmol/l of the cyclooxygenase inhibitors acetylsalicylic acid (ASA) or indomethacin in concentrations 2 5 or 5-0 mmol/I to the perfusate significantly (p<0Ol) increased PEG 400 and water absorption. The simultaneous addition of 1.0 pg/mi of exogenous PGE2 to the perfusate with 5 mmol/l of ASA or with 2*5 mmolI of indomethacin reversed the increase of PEG 400 and water transport (p<OOl).
PEG 400 and water absorption. Addition of 5 mmol/l of the cyclooxygenase inhibitors acetylsalicylic acid (ASA) or indomethacin in concentrations 2 5 or 5-0 mmol/I to the perfusate significantly (p<0Ol) increased PEG 400 and water absorption. The simultaneous addition of 1.0 pg/mi of exogenous PGE2 to the perfusate with 5 mmol/l of ASA or with 2*5 mmolI of indomethacin reversed the increase of PEG 400 and water transport (p<OOl).
There were no differences in PEG 400 and water absorption when PGE2 was given alone or in combination with ASA or indomethacin. This study suggests that endogenous or exogenous prostanoids play an important role in the regulation of PEG 400 permeation. PGE2 and NSAIDS modify PEG 400 permeation in parallel with changes in water transport indicating that their effect on permeability is through changes in solvent drag. These findings provide a mechanism which might explain the increase in PEG 400 intestinal permeability in Crohn's disease patients and the increase in intestinal permeability found in patients receiving NSAIDS.
The selective ability of the intestinal epithelium to provide a barrier to the absorption of potentially harmful compounds is often referred to as permeability. Abnormal permeability may be important in the pathogenesis and pathophysiology of various diseases such as coeliac disease,' 2 rheumatoid arthritis,3 indomethacin-associated enteritis,45 and Crohn's disease. 6 PEG 400 is a water soluble mixture of at least nine different polymers, ranging in molecular weight from 242 to 594 daltons and has an average cross sectional diameter of 0 53 nm. Polyethylene glycol 400 was introduced as an 'ideal' probe for measuring intestinal permeability by Chadwick and his colleagues. ' We have recently described increased permeability of PEG 400 in patients with Crohn's disease and their clinically healthy relatives.8 The mechanisms which are responsible for this increase in PEG 400 permeability, however, are not presently understood. In our previous work we found that passive absorption modulated by solvent drug is the main mechanism of PEG 400 permeation.9
The purpose of this study was to examine the possible relationship between prostaglandins and non-steroidal anti-inflammatory drugs on the small intestinal permeation of PEG 400. We questioned the possible relationship between prostaglandins and PEG 400 absorption because prostaglandins are known to affect sodium and water transport in the small intestine"''2 Moreover, an increased concentration of prostaglandins in colonic mucosa is found in patients with ulcerative colitis'3 and Crohn's disease. ' 0 6), and 1-2 (1-2) ml/100 cm/h were recorded at 16,16,-dimethyl prostaglandin E2 concentrations of 0 5, 1-0, and 1 5 mg/ml respectively (Fig 1) . PEG 400 absorption was linearly related to time (three hours) of perfusion in control group (r=0-97) and in group perfused with 1 ,ug/ml of 16,16,-dimethyl prostaglandin E2 (r=0-98) (Fig 2) . Polyethylene glycol 400 absorption was similar between the control groups (13-1 (0-5) [imol/ 100 cm/h), the group perfused with 10% ethyl alcohol in the basic perfusate solution (13 6 (0-3) imol/100 cm/h), and in group perfused with 1-0 mmol/l indomethacin (119 (1-1) ,tmol/100 cm/ h), but was significantly (p<0-01) increased in the rats perfused with higher (2 5 mmol/l and 5 *0 mmol/l) concentrations of indomethacin (17-4 (0-5) and (1 -1) [imol/I00 cm/h respectively).
Water absorption was similar in control group (8-9 (0-4) ml/I00 cm/h), the group perfused with 10% ethyl alcohol in the standard Krebs-phosphate saline buffer (9-6 (1-2) ml/100 cm/h), and in group perfused with 1-0 mmol/l indomethacin (7-1 (0-8) ml/100 cm/h), but significantly (p<0-01) higher in the rats perfused with higher (2-5 mmol/l and 5 -0 mmol/1) concentrations of indomethacin (11-9 (0 5) and 11-6 (0 8) ml/100 cm/h respectively). The results are illustrated in Figure 4 . No differences were found in PEG 400 and water absorption between rats perfused with 2-5 and 5 -0 mmol/l of indomethacin. PEG 400 absorption was linearly related to time (three hours) of perfusion with 2-5 mmol/I indomethacin (r=0-98) (Fig 2) . prostaglandin E2 in 10% ethyl alcohol solution in the standard Krebs-phosphate saline buffer. Addition of both indomethacin and 16,16,-dimethyl prostaglandin E2 significantly (p<0-01) decreased PEG 400 and water absorption compared to the control values (Table) . There were no significant differences in PEG 400 and water absorption between rats perfused with both indomethacin with 16, 16 ,-dimethyl prostaglandin E2 and rats perfused by 16,16,-dimethyl prostaglandin E2 alone.
Discussion
We studied the influence of exogenous 16,16,-dimethyl prostaglandin E2 (PGE2) and cyclooxygenase inhibitors on the intestinal absorption of PEG 400 because of the known influence of prostaglandins on water transport and because of the documented increase in prostaglandins in the lumen and in the mucosa of patients with inflammatory bowel disease. 3 We have previously established that the rate and the direction of water transport are major factors which regulate and modulate the intestinal permeation of PEG 400 and PEG 900. 18 The present data show that endogenous and exogenous prostaglandins are also potent regulators of PEG 400 permeation through regulation of net water flow.
In the present study we found that the addition of PGE2 in concentrations of 0-5, 1-0, and 15 [tg/ml to the perfusate resulted in parallel decrease in both PEG 400 and water absorption (Fig 1) . When we added the cyclooxygenase inhibitor ASA in concentration of 5 mmol/l or indomethacin in concentrations of 2-5 and 5 0 mmol/l the absorption of PEG 400 and water increased (Figs 3, 4) . The increase in transport was reversed by the simultaneous addition to the perfusate of exogenous PGE2 (Table) . These experiments clearly show that PGE2, ASA and indomethacin change PEG 400 permeation in parallel with water absorption. We concluded that ASA and indomethacin influenced PEG 400 and water absorption by blocking the cyclooxygenase pathway and thereby decreasing endogenous synthesis of prostanoids.
Our observations are in concert with the findings of Bjarnson et al, who showed that NSAID increased permeability of "Cr-EDTA. 4 Our findings provide an explanation and a mechanism which could account for Bjarnson's results. By giving NSAID to the patients with rheumatologic disorders or to normal volunteers, the endogenous synthesis of prostaglandins was decreased by blocking the cyclooxygenase enzyme system and intestinal permeability of 5Cr-EDTA and water increased.
At this point, we can only speculate as to the mechanisms by which endogenous or exogenous prostaglandins inhibit water absorption and PEG 400 permeation. Our previous data clearly indicate that PEG 400 and PEG 900 absorption is modulated by solvent drag. As net water absorption increases, net PEG 400 and PEG 900 permeation follow.98 PEG 400 penetration of the intestinal barrier is mediated by two separate forces -simple passive diffusion along its concentration gradient and solvent drag or convection. In the small intestine we found that 43% of the total transport was the result of diffusion while 57% of the transport was mediated by convection.9 In the colon, only 14-3% of total PEG 400 transport is caused by passive diffusion while 85-7% was due to convection (submitted data). Thus permeability changes after NSAID or ASA administration are probably secondary to changes in water flux which in turn are regulated by the concentration of prostaglandins in the mucosa.
There are data which suggest that the inhibitory effect ofprostaglandins on net water absorption may be mediated, at least in part, by prostaglandin effect on sodium and chloride transport. Sernka and coworkers showed that PGE2 inhibited sodium absorption and stimulated chloride secretion in vitro.'9 These changes would result in decreased net water absorption.
It has been shown that PGE2 stimulates mucosal adenylate cyclase through cyclic 3' 5'-AMP as a mediator, similar to cholera exotoxin20 and cyclic 3' 5'-AMP stimulates active secretion of chloride and inhibits the active absorption of sodium.2' Therefore, a possible mechanism by which prostaglandins may inhibit water and PEG 400 absorption is by their effect of stimulating mucosal cyclic 3' 5'-AMP. In Water transport occurs secondary to osmotic forces, and is influenced by active sodium, glucose and amino acid absorption. According to recent reports some hydrophilic electrically neutral molecules are absorbed by osmotic forces, mostly through the paracellular pathway.24 It has been shown that sodium coupled active transport increases fluid absorption through intercellular junctions.25 These physiological changes correlate well with the morphological changes seen on light microscopy, transmission electron microscopy, and freeze fracture techniques which showed dilatation of tight junction after perfusion with glucose, alanine or leucine.26 In addition it has been shown that junctional dilatation is an active process involving contractile proteins of the terminal web and can be affected by cAMP.27 Therefore prostaglandins can be modulators of junctional permeability by acting through cAMP. Decrease in PEG 400 and water absorption by PGE2 in the present work correlate well with the results obtained by Duffey et al. 23 They showed in Necturus gall bladder epithelium that cyclic AMP increased the resistance to passive ion flow through the paracellular pathway by aggregation of microfilaments in regions adjacent to the tight junctions.
In summary our studies show that 16,16,-dimethyl prostaglandin E2 decreased PEG 400 permeability in parallel with decreasing water absorption. Non-steroidal anti-inflammatory drugs increased PEG 400 and water absorption probably by decreasing endogenous mucosal prostanoid synthesis. We conclude that prostaglandins are potent regulators of PEG 400 intestinal permeability through their direct and indirect effects on water transport. As permeability changes are potentially related to the pathogenesis of Crohn's disease28 these observations are important in clarifying our understanding of inflammatory bowel disease.
